Work: US Agency for International Development, USA
Dr Dennis Carroll currently serves as the Director of the U.S. Agency for International Development’s (USAID) Pandemic Influenza and other Emerging Threats Unit. In this position Dr. Carroll is responsible for providing strategic and operational leadership for the Agency’s programs addressing new and emerging disease threats, which has included leading the Agency’s response to the H5N1 avian influenza and H1N1 pandemic viral threats. He is presently coordinating the roll-out of USAID’s new Emerging Pandemic Threats program – a global effort to combat new disease threats before they can become significant threats to human health.
Dr Carroll was initially detailed to USAID from the U.S. Centers for Disease Control and Prevention as a senior public health advisor in 1991. In 1995 he was named the Agency’s Senior Infectious Diseases advisor, responsible for overseeing the Agency’s programs in malaria, tuberculosis, antimicrobial resistance, disease surveillance, as well as neglected and emerging infectious diseases. In this capacity Dr. Carroll was directly involved in the development and introductionof a range of new technologies for disease prevention and control, including: community-based delivery of treatment of onchocerciasis, rapid diagnostics for malaria, new treatment therapies for drug resistant malaria, intermittent therapy for pregnant women and “longlasting” insecticide treated bednets for prevention of malaria. He was responsible for the initial design and development of the President’s Malaria Initiative. Dr. Carroll officially left CDC and joined USAID in 2005 when he assumed responsibility for leading the USAID response to the spread of avian influenza.
Dr Carroll has a doctorate in biomedical research with a special focus in tropical infectious diseases from the University of Massachusetts at Amherst. He was a Research Scientist at Cold Spring Harbor Laboratory where he studied the molecular mechanics of viral infection. Dr. Carroll has received awards from both CDC and USAID, including the 2006 USAID Science and Technology Award for his work on malaria and avian influenza, and the 2008 Administrator’s Management Innovation Award for his management of the Agency’s Avian and Pandemic Influenza program.